Article -> Article Details
Title | Oral Anticoagulants Market Segmentation and Analysis by 2023 |
---|---|
Category | Fitness Health --> Addictions |
Meta Keywords | Oral Anticoagulants Market |
Owner | vinit |
Description | |
Market Research Future (MRFR) recognizes the following
companies as the key players in the global oral anticoagulants market that
includes AstraZeneca, Plc (UK), Pfizer (US), Boehringer Ingelheim GmbH
(Germany), Daiichi Sankyo Company Ltd (Japan), Abbott Laboratories (US), Eli
Lilly and Company (US), GlaxoSmithKline plc (UK) Portola Pharmaceuticals Inc.
(US), Medicure (Canada), Johnson & Johnson Services Inc. (US), and others. Market Highlights The Global Oral
Anticoagulants Market is expected to grow at CAGR of 12.50% to reach
USD 22,561.24 million by 2023 Anticoagulant is a drug, when added to blood, prevents it
from clotting. Anticoagulants achieve their effect by suppressing the synthesis
or function of various clotting factors that are normally present in the blood.
Such drugs are often used to prevent the formation of blood clots (thrombi) in
the veins or arteries or the enlargement of a clot that is circulating in the
bloodstream. Increasing cardiovascular disorders, rising geriatric
population, and increasing surgical procedures support the growth of the global
oral anticoagulants market in recent years. However, the high cost is
likely to restrain market growth over the forecast period. Segment Analysis The global oral anticoagulants market has been segmented
into product, disease indication, distribution channel, and region. Based on
product, the oral anticoagulants market has been segmented into novel oral
anticoagulant and warfarin. On the basis of disease indication, the global oral
anticoagulants market has been segmented into atrial fibrillation (AF)/ stroke
prevention and deep vein thrombosis/ pulmonary embolism, and others. On the
basis of distribution channel, the global oral anticoagulants market has been
segmented into hospital pharmacies, retail pharmacies, and E-commerce. Regional Analysis Geographically, the Americas is expected to dominate the
global oral anticoagulants market. This is owing to increasing
cardiovascular disorders and increasing surgical procedures. Europe showed a
considerable amount of growth in the market due to the rising geriatric
population. Asia-Pacific is estimated to be the fastest growing region in the
market. This is owing to increasing cardiovascular disorders and rising
geriatric population. On the other hand, the Middle East & Africa has the
least share of the market. Key Findings of the Study:
This research report provides the insights, on various
levels of analyses such as industry analysis, market share analysis leading market
players and their profiles. This report also helps in studying the target
segments by providing views on emerging & high-growth segments and market
conclusion. Together the market data comprise and discuss with the basic
assessments on the competitive scenarios & strategies, of the Global
Oral Anticoagulants Market, including the high-growth regions and their
political, economic and technological environments. Furthermore, the project
report also provides the views over the historical market values as well as,
pricing and cost analysis of the same. |